Literature DB >> 18837054

Molecular characterization of a patient with 3p deletion syndrome and a review of the literature.

Thomas V Fernandez1, I J García-González, Christopher E Mason, G Hernández-Zaragoza, V C Ledezma-Rodríguez, V M Anguiano-Alvarez, R E'Vega, M Gutiérrez-Angulo, M L Maya, H E García-Bejarano, M González-Cruz, S Barrios, R Atorga, M G López-Cardona, J Armendariz-Borunda, Matthew W State, Nory O Dávalos.   

Abstract

3p deletion syndrome is a rare disorder involving developmental delay, dysmorphic physical features, and growth retardation. Molecular mapping of several cases in the literature have identified a critical region on chromosome 3p26. We present a child patient with characteristic features of 3p deletion syndrome and a de novo unbalanced translocation involving chromosomes 3 and 13. Fine mapping of this rearrangement using fluorescence in situ hybridization (FISH) and array-based comparative genomic hybridization (aCGH) revealed an unbalanced abnormality including a 4.5 Mb terminal deletion of chromosome 3p, telomeric to ITPR1 on 3p26.2, which was not previously identified with routine cytogenetic analysis. In addition, these investigations confirmed and refined the boundaries of a 26.5 Mb deletion of chromosome 13. This study confirms the minimal candidate region for 3p deletion syndrome, provides further evidence implicating haploinsufficiency of CNTN4 in the disorder, and demonstrates the utility of high-resolution investigations of rare chromosomal rearrangements. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18837054     DOI: 10.1002/ajmg.a.32533

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  12 in total

1.  The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.

Authors:  L Shan; L Ambroisine; J Clark; R J Yáñez-Muñoz; G Fisher; S C Kudahetti; J Yang; S Kia; X Mao; A Fletcher; P Flohr; S Edwards; G Attard; J De-Bono; B D Young; C S Foster; V Reuter; H Moller; T D Oliver; D M Berney; P Scardino; J Cuzick; C S Cooper; Y-J Lu
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-02-23       Impact factor: 5.554

Review 2.  Neurobiology of autism gene products: towards pathogenesis and drug targets.

Authors:  Kristel T E Kleijer; Michael J Schmeisser; Dilja D Krueger; Tobias M Boeckers; Peter Scheiffele; Thomas Bourgeron; Nils Brose; J Peter H Burbach
Journal:  Psychopharmacology (Berl)       Date:  2014-01-14       Impact factor: 4.530

3.  Contactin 4 as an autism susceptibility locus.

Authors:  Catherine E Cottrell; Natalie Bir; Elizabeth Varga; Carlos E Alvarez; Samuel Bouyain; Randall Zernzach; Devon L Thrush; Johnna Evans; Michael Trimarchi; Eric M Butter; David Cunningham; Julie M Gastier-Foster; Kim L McBride; Gail E Herman
Journal:  Autism Res       Date:  2011-02-09       Impact factor: 5.216

4.  Structural genomic variation in childhood epilepsies with complex phenotypes.

Authors:  Ingo Helbig; Marielle E M Swinkels; Emmelien Aten; Almuth Caliebe; Ruben van 't Slot; Rainer Boor; Sarah von Spiczak; Hiltrud Muhle; Johanna A Jähn; Ellen van Binsbergen; Onno van Nieuwenhuizen; Floor E Jansen; Kees P J Braun; Gerrit-Jan de Haan; Niels Tommerup; Ulrich Stephani; Helle Hjalgrim; Martin Poot; Dick Lindhout; Eva H Brilstra; Rikke S Møller; Bobby P C Koeleman
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

5.  Developmental role of the cell adhesion molecule Contactin-6 in the cerebral cortex and hippocampus.

Authors:  Amila Zuko; Asami Oguro-Ando; Roland van Dijk; Sara Gregorio-Jordan; Bert van der Zwaag; J Peter H Burbach
Journal:  Cell Adh Migr       Date:  2016-03-03       Impact factor: 3.405

Review 6.  Regulation of the postsynaptic cytoskeleton: roles in development, plasticity, and disorders.

Authors:  Tatyana Svitkina; Wan-Hsin Lin; Donna J Webb; Ryohei Yasuda; Gary A Wayman; Linda Van Aelst; Scott H Soderling
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

7.  Trisomy 1q41-qter and monosomy 3p26.3-pter in a family with a translocation (1;3): further delineation of the syndromes.

Authors:  Alicia Cervantes; Constanza García-Delgado; Fernando Fernández-Ramírez; Carolina Galaz-Montoya; Ariadna Berenice Morales-Jiménez; Karem Nieto-Martínez; Laura Gómez-Laguna; Judith Villa-Morales; Mónica Quintana-Palma; Jaime Berúmen; Susana Kofman; Verónica F Morán-Barroso
Journal:  BMC Med Genomics       Date:  2014-09-15       Impact factor: 3.063

8.  A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome.

Authors:  Walter Arancio; Swonild Ilenia Genovese; Lucia Bongiovanni; Claudio Tripodo
Journal:  Oncoscience       Date:  2015-11-11

9.  Chromosome 3p Inverted Duplication with Terminal Deletion: Second Postnatal Case Report with Additional Clinical Features.

Authors:  Jacquelyn D Riley; Catherine M Stefaniuk; Francine Erenberg; Angelika L Erwin; Lauren Palange; Caroline Astbury
Journal:  Case Rep Genet       Date:  2019-07-25

10.  TAMM41 is required for heart valve differentiation via regulation of PINK-PARK2 dependent mitophagy.

Authors:  Rui Meng Yang; Jiong Tao; Ming Zhan; Hao Yuan; Hai Hong Wang; Sai Juan Chen; Zhu Chen; Hugues de Thé; Jun Zhou; Ying Guo; Jun Zhu
Journal:  Cell Death Differ       Date:  2019-03-01       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.